NCT01928368 - A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Asthma

Interventions

DRUG

AMG 282

Single dose either subcutaneously or intravenously on day 1.

DRUG

AMG 282 Matching Placebo

Single dose of matching AMG 282 placebo either subcutaneously or intravenously on day 1.

Trial Locations (5)

Research Site, Raleigh

Research Site, Aventura

Research Site, Lenexa

Research Site, Cypress

Research Site, Seattle